Charles Schwab
SGHT icon

Charles Schwab’s Sight Sciences SGHT Stock Holding History

Charles Schwab’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.49M Sell
275,553
-3,036
-1% -$14K ﹤0.01% 2884
2026
Q1 		$1.05M Sell
278,589
-10,309
-4% -$55.6K ﹤0.01% 2893
2025
Q4 		$2.29M Buy
288,898
+12,760
+5% +$81.5K ﹤0.01% 2722
2025
Q3 		$950K Buy
276,138
+9,826
+4% +$36.6K ﹤0.01% 2966
2025
Q2 		$1.1M Buy
266,312
+42,661
+19% +$142K ﹤0.01% 2868
2025
Q1 		$537K Sell
223,651
-44,599
-17% -$126K ﹤0.01% 3056
2024
Q4 		$976K Buy
268,250
+11,259
+4% +$51.3K ﹤0.01% 2920
2024
Q3 		$1.62M Buy
256,991
+1,873
+0.7% +$12.6K ﹤0.01% 2770
2024
Q2 		$1.7M Buy
255,118
+34,431
+16% +$204K ﹤0.01% 2754
2024
Q1 		$1.17M Buy
220,687
+23,731
+12% +$112K ﹤0.01% 2743
2023
Q4 		$1.02M Sell
196,956
-29,478
-13% -$91K ﹤0.01% 2825
2023
Q3 		$763K Buy
226,434
+40,109
+22% +$263K ﹤0.01% 2887
2023
Q2 		$1.54M Buy
186,325
+1,229
+0.7% +$11.1K ﹤0.01% 2635
2023
Q1 		$1.62M Buy
185,096
+1,627
+0.9% +$18.1K ﹤0.01% 2579
2022
Q4 		$2.24M Buy
183,469
+3,324
+2% +$31.6K ﹤0.01% 2535
2022
Q3 		$1.14M Buy
180,145
+87,331
+94% +$738K ﹤0.01% 2748
2022
Q2 		$835K Sell
92,814
-9,457
-9% -$83.2K ﹤0.01% 2863
2022
Q1 		$1.18M Buy
102,271
+26,749
+35% +$412K ﹤0.01% 2787
2021
Q4 		$1.33M Buy
75,522
+942
+1% +$20.7K ﹤0.01% 2807
2021
Q3 		$1.69M Buy
+74,580
New +$2.45M ﹤0.01% 2740

Other funds holding SGHT

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Charles Schwab's SGHT Position: Q2 2026 in Review

Charles Schwab reduced its Sight Sciences (SGHT) stake by 1.1% in Q2 2026, selling an estimated $14K and leaving 275,553 shares worth $1.49M. The position accounts for ﹤0.01% of the portfolio, ranked #2884.

Charles Schwab first reported a position in SGHT in Q3 2021 and has held it in 20 quarters since. The position peaked at $2.29M in Q4 2025. 112 funds tracked by Wall St. Rank hold SGHT as of Q2 2026.

  • Charles Schwab held 275,553 shares of Sight Sciences worth $1.49M as of Q2 2026.
  • Charles Schwab sold 3,036 Sight Sciences shares in Q2 2026, an estimated $14K.
  • Sight Sciences made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2884 holding.
  • Charles Schwab first reported a position in Sight Sciences in Q3 2021 and has held it in 20 quarters since.
  • Charles Schwab's Sight Sciences position peaked at $2.29M in Q4 2025.
  • 112 funds tracked by Wall St. Rank held Sight Sciences as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.